5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18351439 | COMBINATION THERAPIES OF WDR-5 INHIBITORS AND PD-1 INHIBITORS | TOWNSLEY, SARA ELIZABETH | 1629 | Non-Final OA | Jul 12, 2023 |
| 18120311 | MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR COMPOUNDS AND USES THEREOF | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | Mar 10, 2023 |
| 17993567 | COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS | WU, JULIE ZHEN QIN | 1643 | Final Rejection | Nov 23, 2022 |
| 17410459 | METHODS AND COMPOSITIONS FOR GENETIC MODULATION OF TUMOR MICROENVIRONMENTS | PECKHAM, RICHARD GRANT | 1627 | Final Rejection | Aug 24, 2021 |
| 16894532 | TRIPLET THERAPIES OF HDAC INHIBITORS, PD-L1 AND/OR PD-1 INHIBITORS, AND CTLA-4 INHIBITORS | BUTTICE, AUDREY L | 1647 | Non-Final OA | Jun 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial